Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors
α-Glucosidase inhibitors (AGIs) are used as medicines for the treatment of diabetes mellitus. The α-Glucosidase enzyme is present in the small intestine and is responsible for the breakdown of carbohydrates into sugars. The process results in an increase in blood sugar levels. AGIs slow down the dig...
Main Authors: | Imran Ahmad Khan, Matloob Ahmad, Usman Ali Ashfaq, Sadia Sultan, Magdi E.A. Zaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/16/4760 |
Similar Items
-
Synthesis of Novel <i>N</i>-Methylmorpholine-Substituted Benzimidazolium Salts as Potential α-Glucosidase Inhibitors
by: Imran Ahmad Khan, et al.
Published: (2022-09-01) -
Crystal structure of benzimidazolium salicylate
by: M. Amudha, et al.
Published: (2015-10-01) -
Synthesis and Crystal Structure of a New Hydrated Benzimidazolium Salt Containing Spiro Structure
by: Wulan Zeng, et al.
Published: (2017-10-01) -
Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2<i>H</i>-benzo[<i>e</i>][1,2]thiazin-2-yl]-<i>N</i>-arylacetamides: An In Silico and Biochemical Approach
by: Furqan Ahmad Saddique, et al.
Published: (2021-05-01) -
Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study
by: Hayat Ullah, et al.
Published: (2022-10-01)